FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/02/040417 [Registered on: 18/02/2022] Trial Registered Prospectively
Last Modified On: 17/02/2022
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Medical Device 
Study Design  Non-randomized, Multiple Arm Trial 
Public Title of Study   Comparison of visual outcomes of SMILE surgery performed for high myopic astigmatism using a software with Visumax 800(a new laser machine) versus manual technique used with Visumax 500(another laser machine) 
Scientific Title of Study   Comparison of visual and refractive outcomes of SMILE performed for high myopic astigmatism[greater than or equals to 1.5 D( /=1.5D)] using the OcuLign software with Visumax 800 versus manual cyclotorsion compensation with Visumax 500 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sri Ganesh 
Designation  Chairman Managing Director 
Affiliation  Nethradhama superspeciality eye hospital  
Address  Nethradhama superspeciality Eye Hospital,256/14,Kanakapura main road,7th block,Jayanagar,banglore

Bangalore
KARNATAKA
560082
India 
Phone    
Fax    
Email  phacomaverick@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sheetal Brar 
Designation  Senior consultant and research director  
Affiliation  Nethradhama superspeciality eye hospital  
Address  Nethradhama superspeciality Eye Hospital,256/14,Kanakapura main road,7th block,Jayanagar,banglore

Bangalore
KARNATAKA
560082
India 
Phone    
Fax    
Email  brar_sheetal@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Hemali Bhavsar 
Designation  Fellow 
Affiliation  Nethradhama superspeciality eye hospital  
Address  Nethradhama superspeciality Eye Hospital,256/14,Kanakapura main road,7th block,Jayanagar,banglore

Bangalore
KARNATAKA
560082
India 
Phone    
Fax    
Email  bhavsarhemali91@gmail.com  
 
Source of Monetary or Material Support  
Nethradhama Superspeciality Eye Hospital,256/14, kanakapura main road,7th block,jayanagar,Banglore, Karnataka,India 
 
Primary Sponsor  
Name  CARL ZEISS MEDITEC 
Address  ZEISS,OBBERKOCHEN,GERMANY 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sheetal Brar  Nethradhama Superspeciality Eye Hospital  Phaco refractive department,2nd floor,OPD block,256/14 Kanakapura main road,Jayanagar,7th block
Bangalore
KARNATAKA 
9591002092

brar_sheetal@yahoo.co.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Nethradhama Superspeciality Eye Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H522||Astigmatism,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Astigmatism treatment by Visumax 800 using OcuLign Software  Visual and Refractive outcomes after using OcuLign software in Visumax800 for astigmatism treatment 
Comparator Agent  Astigmatism treatment by Visumax500 using manual cyclotorsion compensation  Visual and Refractive outcomes after using manual cyclotorsion compensation for astigmatism with Visumax500 
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  1)SE between -1D to -10D
2)Astigmatism upto -5D 
 
ExclusionCriteria 
Details  1)keratoconus
2)Pellucid marginal degeneration or suspect cornea
3)severe dry eye or meibomian gland disease
4)glaucoma
5)retinal diseases
6)pregnancy
7)patients on immunosupressants
8)patients with unassured follow up 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To evaluate the outcomes of astigmatism correction with the use of OcuLign software in Visumax800  1)post-op day1
2)post-op day7
3)post-op day180 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate safety and efficacy of OcuLign software in Visumax 800  1)post day1
2)post-op day7
3_post-op day 180 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/02/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   To evaluate the visual and refractive outcomes of SMILE surgery performed for high myopic astigmatism (>/= 1.5 D) using OcuLign software and the results will be compared with VIsual and refractive outcomes of SMILE surgery performed for high astigmatism using Manual cyclotorsion compensation used with Visumax500 laser machine. A total of 50 eyes treated with Visumax800 satisfying inclusion criteria will be taken into study.Post-operatively this data will be analysed with a retrospective data of another 50 eyes from 50 patients who underwent SMILE for myopic astigmatism treated with manual compensation using ink marking method with the visumax500 femto laser. 
Close